New Data Continue to Show Significant and Sustained Blood ... | 合法醫療器材資訊網
![New Data Continue to Show Significant and Sustained Blood ...](https://i.imgur.com/6y29Lx7.jpg)
2013年10月28日—TheBostonScientificVessixSystemistheonlyrenaldenervationsystemtoutilizebipolarenergytodisruptthesenerves,providingamore ...
![New Data Continue to Show Significant and Sustained Blood ...](https://i.imgur.com/6y29Lx7.jpg)
New Data Continue to Show Significant and Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
SAN FRANCISCO, Oct. 28, 2013 /PRNewswire[1]/ -- Patients treated with the Boston Scientific (NYSE: BSX) Vessix™ Renal Denervation System experienced a significant and sustained reduction in blood pressure, according to new data presented today at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco. An interim analysis of 139 patients enrolled in the REDUCE-HTN post market study affirms the device safety profile and effective treatment for resistant hypertension.
"In the REDUCE-HTN study, 85 percent of patients treated with the Vessix System experienced a clinically-meaningful decrease in blood pressure," said Professor Horst Sievert, M.D., Ph.D., director of the CardioVascular Center Frankfurt, Sankt Katharinen Hospital in Frankfurt, Germ...
Boston Scientific Begins Novel REDUCE | 合法醫療器材資訊網
Boston Scientific Enrolls First Patient In New Study Designed ... | 合法醫療器材資訊網
Boston Scientific Vessix™ Renal Denervation System ... | 合法醫療器材資訊網
Boston Scientific's Vessix renal denervation system ... | 合法醫療器材資訊網
HYPERTENSION | 合法醫療器材資訊網
New Data Continue to Show Significant and Sustained Blood ... | 合法醫療器材資訊網
Prematurely Halted Pilot Study Snaps Recent Winning Streak ... | 合法醫療器材資訊網
Renal denervation trial stopped | 合法醫療器材資訊網
Renal Denervation Using the Vessix Renal Denervation ... | 合法醫療器材資訊網
Vessix Media Factsheet | 合法醫療器材資訊網
![](https://i.imgur.com/6y29Lx7.jpg)
【“波士頓科技”腎交感神經阻斷系統】許可證字號:衛部醫器輸字第025777號
器材品名:“波士頓科技”腎交感神經阻斷系統許可證字號:衛部醫器輸字第025777號註銷狀態:已註銷註銷日期:2017/09/08註銷理由:...